Overview
- 66 inspections across 59 sites are on record.
- 183 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2021-04-02.
At a glance
Inspections
66
Sites
59
Observations
183
Career since
May 2013
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| WuXi Biologics Co., Ltd. | 2 Apr 2021 | Human Drugs | On file |
| Zhejiang Poly Pharm. Co., Ltd | 4 Dec 2020 | Human Drugs | On file |
| Shandong Anhong Pharmaceutical Co., Ltd. | 30 Oct 2020 | Human Drugs | On file |
| The United Laboratories (Inner Mongolia) Co., Ltd. | 14 Jan 2020 | Human Drugs | On file |
| Viwit Pharmaceutical Co., Ltd. | 18 Oct 2019 | Human Drugs | On file |
Sites inspected
WuXi Biologics Co., Ltd.Wuxi, China1 insp.
Zhejiang Poly Pharm. Co., LtdHangzhou, China1 insp.
Shandong Anhong Pharmaceutical Co., Ltd.Dezhou, China1 insp.
The United Laboratories (Inner Mongolia) Co., Ltd.Bayan Nur, China1 insp.
Viwit Pharmaceutical Co., Ltd.Tengzhou, China1 insp.
Co-investigators
Investigators who share inspections with this person.
Collins M Mason6 shared
Qin Xu5 shared
Marcus A Ray5 shared
Brooke K Higgins3 shared
Chaltu N Wakijra2 shared
Rebecca Rodriguez2 shared
Jai P Singh2 shared
Eric L Dong2 shared
Toyin B Oladimeji2 shared
Jessica L Pressley2 shared
Full investigator report
Get the verbatim findings behind Jonathan W Chapman's 183 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site